These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 26337818

  • 21. Antidiuretic action of oxytocin is associated with increased urinary excretion of aquaporin-2.
    Joo KW, Jeon US, Kim GH, Park J, Oh YK, Kim YS, Ahn C, Kim S, Kim SY, Lee JS, Han JS.
    Nephrol Dial Transplant; 2004 Oct; 19(10):2480-6. PubMed ID: 15280526
    [Abstract] [Full Text] [Related]

  • 22. [Nephrogenic diabetes insipidus].
    Bichet DG.
    Nephrol Ther; 2006 Nov; 2(6):387-404. PubMed ID: 17081961
    [Abstract] [Full Text] [Related]

  • 23. Nephrogenic Diabetes Insipidus.
    Kavanagh C, Uy NS.
    Pediatr Clin North Am; 2019 Feb; 66(1):227-234. PubMed ID: 30454745
    [Abstract] [Full Text] [Related]

  • 24. Bypassing vasopressin receptor signaling pathways in nephrogenic diabetes insipidus.
    Bouley R, Hasler U, Lu HA, Nunes P, Brown D.
    Semin Nephrol; 2008 May; 28(3):266-78. PubMed ID: 18519087
    [Abstract] [Full Text] [Related]

  • 25. Novel treatment for lithium-induced nephrogenic diabetes insipidus rat model using the Sendai-virus vector carrying aquaporin 2 gene.
    Suga H, Nagasaki H, Kondo TA, Okajima Y, Suzuki C, Ozaki N, Arima H, Yamamoto T, Ozaki N, Akai M, Sato A, Uozumi N, Inoue M, Hasegawa M, Oiso Y.
    Endocrinology; 2008 Nov; 149(11):5803-10. PubMed ID: 18653713
    [Abstract] [Full Text] [Related]

  • 26. Cooperative mechanisms involved in chronic antidiuretic response to bendroflumethiazide in rats with lithium-induced nephrogenic diabetes insipidus.
    Moosavi SM, Karimi Z.
    Acta Physiol Hung; 2014 Mar; 101(1):88-102. PubMed ID: 24631797
    [Abstract] [Full Text] [Related]

  • 27. Nephrogenic diabetes insipidus.
    Bichet DG.
    Adv Chronic Kidney Dis; 2006 Apr; 13(2):96-104. PubMed ID: 16580609
    [Abstract] [Full Text] [Related]

  • 28. Hsp90 inhibitor partially corrects nephrogenic diabetes insipidus in a conditional knock-in mouse model of aquaporin-2 mutation.
    Yang B, Zhao D, Verkman AS.
    FASEB J; 2009 Feb; 23(2):503-12. PubMed ID: 18854434
    [Abstract] [Full Text] [Related]

  • 29. Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus.
    Robben JH, Knoers NV, Deen PM.
    Am J Physiol Renal Physiol; 2006 Aug; 291(2):F257-70. PubMed ID: 16825342
    [Abstract] [Full Text] [Related]

  • 30. Acetazolamide Attenuates Lithium-Induced Nephrogenic Diabetes Insipidus.
    de Groot T, Sinke AP, Kortenoeven ML, Alsady M, Baumgarten R, Devuyst O, Loffing J, Wetzels JF, Deen PM.
    J Am Soc Nephrol; 2016 Jul; 27(7):2082-91. PubMed ID: 26574046
    [Abstract] [Full Text] [Related]

  • 31. Clinical characteristics of eight patients with congenital nephrogenic diabetes insipidus.
    Mizuno H, Sugiyama Y, Ohro Y, Imamine H, Kobayashi M, Sasaki S, Uchida S, Togari H.
    Endocrine; 2004 Jun; 24(1):55-9. PubMed ID: 15249704
    [Abstract] [Full Text] [Related]

  • 32. Disordered water channel expression and distribution in acquired nephrogenic diabetes insipidus.
    Marples D, Frøkiaer J, Knepper MA, Nielsen S.
    Proc Assoc Am Physicians; 1998 Jun; 110(5):401-6. PubMed ID: 9756090
    [Abstract] [Full Text] [Related]

  • 33. Novel AQP2 mutation causing congenital nephrogenic diabetes insipidus: challenges in management during infancy.
    Rugpolmuang R, Deeb A, Hassan Y, Deekajorndech T, Shotelersuk V, Sahakitrungruang T.
    J Pediatr Endocrinol Metab; 2014 Jan; 27(1-2):193-7. PubMed ID: 23950570
    [Abstract] [Full Text] [Related]

  • 34. Wnt5a induces renal AQP2 expression by activating calcineurin signalling pathway.
    Ando F, Sohara E, Morimoto T, Yui N, Nomura N, Kikuchi E, Takahashi D, Mori T, Vandewalle A, Rai T, Sasaki S, Kondo Y, Uchida S.
    Nat Commun; 2016 Nov 28; 7():13636. PubMed ID: 27892464
    [Abstract] [Full Text] [Related]

  • 35. Reverse pharmacological effect of loop diuretics and altered rBSC1 expression in rats with lithium nephropathy.
    Michimata M, Fujita S, Araki T, Mizukami K, Kazama I, Muramatsu Y, Suzuki M, Kimura T, Sasaki S, Imai Y, Matsubara M.
    Kidney Int; 2003 Jan 28; 63(1):165-71. PubMed ID: 12472779
    [Abstract] [Full Text] [Related]

  • 36. Nephrogenic diabetes insipidus persisting 57 months after cessation of lithium carbonate therapy: report of a case and review of the literature.
    Guirguis AF, Taylor HC.
    Endocr Pract; 2000 Jan 28; 6(4):324-8. PubMed ID: 11242610
    [Abstract] [Full Text] [Related]

  • 37. Methyl-beta-cyclodextrin induces vasopressin-independent apical accumulation of aquaporin-2 in the isolated, perfused rat kidney.
    Russo LM, McKee M, Brown D.
    Am J Physiol Renal Physiol; 2006 Jul 28; 291(1):F246-53. PubMed ID: 16449354
    [Abstract] [Full Text] [Related]

  • 38. Acquired nephrogenic diabetes insipidus.
    Khanna A.
    Semin Nephrol; 2006 May 28; 26(3):244-8. PubMed ID: 16713497
    [Abstract] [Full Text] [Related]

  • 39. Secondary oxalosis induced by xylitol concurrent with lithium-induced nephrogenic diabetes insipidus: a case report.
    Takayasu S, Kamba A, Yoshida K, Terui K, Watanuki Y, Ishigame N, Mizushiri S, Tomita T, Nakamura K, Yasui-Furukori N, Daimon M.
    BMC Nephrol; 2020 May 01; 21(1):157. PubMed ID: 32357847
    [Abstract] [Full Text] [Related]

  • 40. A novel mechanism in recessive nephrogenic diabetes insipidus: wild-type aquaporin-2 rescues the apical membrane expression of intracellularly retained AQP2-P262L.
    de Mattia F, Savelkoul PJ, Bichet DG, Kamsteeg EJ, Konings IB, Marr N, Arthus MF, Lonergan M, van Os CH, van der Sluijs P, Robertson G, Deen PM.
    Hum Mol Genet; 2004 Dec 15; 13(24):3045-56. PubMed ID: 15509592
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.